the European Institute of Oncology
Published by:
Education
Key Advances in Clinical Practice Series
ecancer are delighted to announce a collaboration with the UK Key Advances in Clinical Practice Series and the British Oncological Association. A series of symposia run in association with King's College London aimed at discussing currently available scientific evidence and expert clinical opinion for the prevention, investigation and management of cancer.
Available to watch now:
- Key Advances in the Effective Management of Colorectal Cancer
- Key Advances in the Effective Management of Hepatocellular Carcinoma
- Key Advances in the Effective Management of Thyroid Cancer
- Key Advances in the Effective Management of Head and Neck Cancer
Key Advances in the Effective Management of Colorectal Cancer
This meeting was supported by GE Healthcare. GE Healthcare had no involvement in the agenda or production of the presentations.
| Speaker | Subject |
| Professor Shirley Hodgson | Molecular and Clinical Genetic aspects of Colorectal Cancer |
| Dr Tamas Hickish | Adjuvant treatment of colorectal cancer: Quantifying the clinical benefits |
| Dr Gary Middleton | The current status of clinical research using the EGFR monoclonal antibodies in colorectal cancer |
| Dr John Bridgewater | The hegemony of Bevacizumab? |
| Professor Dion Morton | Current and planned clinical trials in CRC |
Key Advances in the Effective Management of Hepatocellular Carcinoma
This meeting was supported by Bayer Healthcare. Bayer Healthcare had no involvement in the agenda or production of the presentations.
| Speaker | Subject |
| Professor Simon Taylor-Robinson | Epidemiology, aetiology and risk of HCC |
| Professor Shirley Hodgson | Molecular and clinical genetics of HCC |
| Professor Phil Robinson | Imaging and Staging |
| Mr Derek Manas | The evidence base for treatment of HCC <2cm |
| Professor Nigel Heaton | The evidence base for treatment of HCC 2-8 cm |
Key Advances in the Effective Management of Thyroid Cancer
This meeting was supported by GE Healthcare. GE Healthcare had no involvement in the agenda or production of the presentations.
| Speaker | Subject |
| Ms Kate Farnell | Patient and public involvement in clinical decision making and service planning |
| Dr Sue Clarke | PET scanning: Does it have a role? |
| Mr Bill Fleming | Surgical Dilemas: The conservative approach |
| Mr David Scott-Coombes | Complications and long term morbidity |
| Mr Barney Harrison | Medullary carcinoma: A conservative or aggressive approach? |
| Dr Musad Haq | 20 year follow up of patients treated by low activity 131I ablation |
| Dr Georgina Gerrard | The national BTA/RCP guidelines: Where are we now? |
| Dr Ujjal Mallick | The enigma of thyroglobulin +ve/131I-negative patients HiLo: The national UK prospective trial |
Key Advances in the Effective Management of Head and Neck Cancer
This meeting was supported by Merck Serono. Merck Serono had no involvement in the agenda or production of the presentations.
| Speaker | Subject |
| Mr Graham Cox | Diagnosis and assessment of lymphadectomy in the neck |
| Mr Terry Jones | Diet and its role in surgical outcome |
| Dr Mehmet Sen | Current advances in chemoradiation for locally advanced head and neck cancer |
| Mr Richard Shaw | Molecular profiling of head and neck cancers - how close are we to predicting the best therapeutic intervention? |
| Professor Gordon Proctor | Pathophysiology, assessment and potential therapeutic options in radiation-induced xerostomia |
| Professor Michelle Saunders | Current status of altered fractionation in locally advanced head and neck cancer |
We will soon direct the community to forthcoming educational initiatives and programmes to be launched by our Founding Partner, ECCO - the European CanCer Organisation. This will enable us to jointly offer a comprehensive choice of educational materials for surgeons, nurses, physicians, radiation specialists, and technologists, general practitioners, counsellors and advocates of cancer care.
